Biosimilars and Biobetters
30 September 2015 - 01 October 2015
With Europe leading the way in the field of Biosimilar development, it is important to get to grips with all areas in the product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments. Every angle should be considered and taken account for through the development process and with the EU the most advanced market for biosimilars, accounting for 80% of global spending on these molecules, the learning curve for biosimilars is essentially still building and there are hurdles to overcome.
Holiday Inn, Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/conference/biosimilars-and-biobetters
Technologies in Drug Discovery Summit Europe
05 October 2015 - 08 October 2015
We are pleased to invite you to the Technologies in Drug Discovery Summit Europe, which will take place October 5-8, 2015 in Berlin, Germany. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.
Technologies in Drug Discovery Summit Europe will consist of two back-to-back conferences:
Conference A: 2nd Bioinformatics & Drug Discovery
Conference B: 2nd Next Generation Sequencing: Opportunities & Challenges
The Technologies in Drug Discovery Summit Europe is also part of our even larger Drug Discovery Week Europe 2015 and coincides with the Biomarker Summit Europe on the same dates.
Ramada Hotel Berlin - Alexanderplatz, Berlin, Germany
https://www.gtcbio.com/conferences/technologies-drug-discovery-summit-overview?utm_source=tddse&utm_medium=EventListing&utm_campaign=overview
2nd Next Generation Sequencing & Bioinformatics Conference
05 October 2015 - 07 October 2015
We welcome you to join us at GTCbio’s 2nd Next Generation Sequencing & Bioinformatics Conference on October 5-7, 2015 in Berlin, Germany. This conference gathers the foremost experts to present on leading-edge technology in next-generation sequencing and bioinformatics featuring discussions on opportunities and challenges in NGS, bioinformatics, and data management.
Join your peers in this one-of-a-kind opportunity to learn from academicians and industry specialists presenting on the top NGS platforms, novel applications, clinical investigations, health economics, transcriptomics, infectious disease investigations, emerging technologies, ancient and forensic DNA studies, whole genome sequencing, single-cell analysis, and more! In addition, the world’s leading bioinformaticians will drill-down on developments in NGS big data, cloud systems, clinical and cancer genomics data, database integration, the Galaxy Project and pipelines, BaseSpace, and much more!
This conference is part our Drug Discovery Week Europe 2015 and coincides with the Biomarker Summit Europe at the same location.
Ramada Hotel Berlin - Alexanderplatz, Berlin, Germany
https://www.gtcbio.com/conferences/next-generation-sequencing-bioinformatics-overview
Biotherapeutics - Innovative Future Medicine
08 October 2015
In the last decades, biotherapeutics have become a valuable and integral part of modern medicine to treat severe diseases such as cancer, diabetes and rheumatoid arthritis. The first use of biotechnological methods was for the production of insulin. Since then many biotherapeutic medicines have been developed for the treatment of severe diseases such as cancer and many autoimmune diseases and multiple rare diseases. Biotherapeutics are especially attractive due to their highly targeted and specific nature and their relatively low safety risk.
This one day meeting will focus on the recent progress made in the fast moving field of biotherapeutics. Experts from academia and industry will highlight the latest development in this exciting area of research.
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
http://www.smr.org.uk/smr/Meetings/20151008/Default.asp
COPD 2015
19 October 2015 - 20 October 2015
Now in its 7th year, COPD 2015 will gather a global audience of respiratory experts and scientific pioneers to discuss the latest developments in combinational therapies, new drugs and personalised treatment as well as the challenges of clinical trials. Join us as we ask questions such as: How does one reliably recruit and run clinical trials in a disease that branches to such extremes? What is the correct phenotype to measure in the disease? With the majority of COPD patients on varying courses of polypharmacy due to a range of different debilitating diseases alongside COPD – how can one find a clean patient? Plus much more!
Holiday Inn Regents Park Hotel, London UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/copd-novel-therapeutics-and-management-strategies?utm_source=P-154&utm_medium=EM%20-%205S&utm_campaign=GroupMail
COPD Novel therapeutics and management strategies
19 October 2015 - 20 October 2015
SMi's 7th annual conference on COPD will bring together respiratory leaders and scientific pioneers to strengthen knowledge in combinational therapies, new drugs and personalised treatment, whilst keeping you at the forefront of scientific breakthroughs to adapt to the growing need for efficiency in the management of exacerbations.
Understanding COPD pulmonary indications through biomarkers and the practicalities of reliable clinical trials will be a major focus as will hearing from a selection of pharmaceutical organisations currently developing scientific trials for COPD. This will include case studies from Novartis, Mundipharma, Janssen, MedImmune and Bayer.
Holiday Inn Regents Park Hotel, London UK
http://www.copd-conference.co.uk/DDT
War on Cancer 2015
20 October 2015
War on Cancer 2015 will bring together the most influential leaders in oncology from around Europe to explore and shape the dialogue on cancer. Join pharmaceutical, health care, scientific and government specialists on October 20th 2015 to discuss the leading initiatives in policy and financing, innovation in prevention, treatment and diagnosis and new methods of community engagement.
THE HAC Armoury House City Road London EC1Y 2BQ
http://www.waroncancer.economist.com
APS Stimulating antimicrobial innovation
22 October 2015
Background to the Meeting:
The pipeline of new antimicrobial agents is critically stagnant with most major pharma players having limited activity in the antibiotics arena over the past three decades. This meeting aims to capture the cutting edge of the antimicrobial innovation in the UK, to understand the barriers to antibiotic discovery, examine innovation ‘hotspots’ in the UK and highlight developments in the current funding landscape for antibiotics discovery and innovation.
The purpose and aims of the APSGB Microbiology and Anti-Infectives Focus Group is to provide a forum for the discussion of all aspects of microbiology and anti-infectives research and development in the pharmaceutical industry and academia, to underpin the importance of microbiology to the pharmaceutical sciences and innovation, and to provide continuing education, resources and a voice for pharmaceutical scientists in the challenging area of antimicrobials development.
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
https://www.apsgb.co.uk/Events/20151022/
3rd Antibody & Protein Therapeutics Conference
22 October 2015 - 23 October 2015
We welcome you to the 3rd Antibody & Protein Therapeutics Conference, which will be held October 22-23, 2015 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.
Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics including antibody drug conjugates, bispecific antibodies, antibody combinations, and check point inhibiting antibodies. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment!
Hyatt Boston Harbour, Boston, MA, USA
https://www.gtcbio.com/conferences/antibody-protein-therapeutics-overview
Antibody Drug Conjugates Conference
22 October 2015 - 23 October 2015
We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics.
With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
Hyatt Boston Harbour, Boston, MA, USA
https://www.gtcbio.com/conferences/antibody-drug-conjugates-overview?utm_source=adc&utm_medium=EventListing&utm_campaign=overview